A Phase 1, Randomized, Double-Blind, Active Comparator Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Novel Pneumococcal Vaccine in Children

Project: Research project

Project Details

StatusActive
Effective start/end date11/7/25 → 11/6/27

Funding

  • Merck Sharp and Cohme Corporation ( Award # ): $15,500.00